Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 1 1

Status

Completed 321Unknown 104Terminated 50Active not recruiting 29Recruiting 21Withdrawn 14Suspended 4Enrolling by invitation 3Not yet recruiting 2

Sponsor Class

OTHER 39INDUSTRY 14NIH 4OTHER_GOV 2

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Sarcoma 5Other hematologic neoplasm 5CNS 5Lymphoid 4Breast 4Thoracic 3Gastrointestinal 3Tumor-Agnostic 2Plasma cell 2Myeloid 2Genitourinary 2Dermatologic 2Other solid neoplasm 1Head & Neck 1Gynecologic 1Classical hematology 1

Conditions

Breast Neoplasms 3Triple Negative Breast Neoplasms 2Prostatic Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1

Interventions

Specimen Handling 2binimetinib 1Radiotherapy 1Neoadjuvant Therapy 1Methotrexate 1Magnetic Resonance Spectroscopy 1Fluorouracil 1Doxorubicin 1Cyclophosphamide 1Chemotherapy, Adjuvant 1CMF regimen 1CAF protocol 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Suspended × NIH × Breast × Clear all
NCT07067138 2026-05-18

A Synthetic Lethality-Focused Algorithm to Identify Therapeutic Options in Advanced Metastatic Breast Cancer (SYNTHESIS-Breast)

National Institutes of Health Clinical Center (CC)

Phase NA Suspended
175 enrolled
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04955808 2026-05-13

Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery

National Cancer Institute (NCI)

Suspended
2,400 enrolled
BreastGastrointestinalGenitourinaryPlasma cell

Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Carcinoma, Hepatocellular, Multiple Myeloma, Prostatic Neoplasms

NCT05111561 2026-05-13

Testing the Combination of the Anticancer Drugs ZEN003694 and Binimetinib in Patients With Advanced/Metastatic or Unresectable Solid Tumors With RAS Alterations and Triple Negative Breast Cancer

National Cancer Institute (NCI)

Phase 1 Suspended
42 enrolled
Breast

Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT00002696 2013-08-02

Combination Chemotherapy in Treating Women With Stage III Breast Cancer

National Cancer Institute (NCI)

Phase 3 Suspended
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡